Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Pharmacyclics

Lilly drops Hanmi-partnered arthritis drug

Lilly drops Hanmi-partnered arthritis drug

The first BTK inhibitor to reach the market was Johnson &Johnson (J&J) and Pharmacyclics' Imbruvica (ibrutinib), but this has been introduced initially for blood cancers including chronic lymphocytic leukaemia (CLL) ... Meanwhile, Pharmacyclics (now part

Deal Watch March 2017

Deal Watch March 2017 name. (Abexinostat was formerly in development by Pharmacyclics (now owned by AbbVie) and Servier.) Both ACAT-1 (for which Xynomic paid $1.2m upfront with another $59m in potential milestones) and

AbbVie and J&J file first non-cancer use for Imbruvica with FDA

AbbVie and J&J file first non-cancer use for Imbruvica with FDA $21bn it paid to purchase ibrutinib's original developer Pharmacyclics in 2015.

Resurgent Actelion catches J&J's eye

Resurgent Actelion catches J&J's eye That may now be changing, as it was rumoured to have been in the running for Pharmacyclics – eventually bought by AbbVie for $21bn – and said earlier this year it was open

Trial of AbbVie's Rova-T disappoints at ASCO

Trial of AbbVie's Rova-T disappoints at ASCO The company has been spending heavily on the acquisition of new assets, for example buying Pharmacyclics and its fast-growing blood cancer therapy Imbruvica (ibrutinib) for $21bn last year.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics